One of the fundamental pillars of the life sciences industry is the accuracy of the claims that it makes for its products. Over decades, the industry has strived to become second to none in terms of testing and transparency, because what it says about its products has the potential to impact ultimately upon hundreds of millions of patients and consumers. And arguably, no other industry is subject to the same level of regulatory scrutiny. James Brown, VP & GM Commercial Content at Veeva/Zinc reflects on the claims management disconnect.
https://international-pharma.com/wp-content/uploads/2016/01/Its-time.pdf
https://international-pharma.com/wp-content/uploads/2016/01/Its-time.pdf
https://international-pharma.com/wp-content/uploads/2016/01/Its-time.pdf